{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:04:40Z","timestamp":1790647480224,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prostate cancer (PCa) progression is strongly influenced by the metabolites available in the tumor microenvironment (TME), including lactic acid (LA), which is actively imported by PCa cells to boost mitochondrial metabolism and drive de novo collagen synthesis, sustaining increased malignancy. LA exploitation promotes the unbalance of tricarboxylic acid (TCA) cycle intermediates, particularly succinate and fumarate, well-known epigenetic modifiers for histone (de)methylation. Here, we show that the LA-induced increase in succinate levels affects the activating H3K4me3 methylation mark in PCa cells, promoting a pro-invasive phenotype. Notably, pharmacological targeting of H3K4me3 using OICR-9429 reduces LA-enhanced PCa cell invasiveness. Moreover, LA-induced H3K4me3 enrichment regulates the expression of procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase 1 (PLOD1), a key enzyme involved in collagen maturation. Genetic impairment of PLOD1 reduces the LA-driven invasive potential of PCa cells, thereby highlighting PLOD1 as a crucial epigenetically regulated mediator of tumor invasion. Overall, our findings uncover a novel LA-fuelled metabolic-epigenetic axis that promotes the H3K4me3-mediated PLOD1 upregulation, consequently fostering PCa aggressiveness and unveiling a potential therapeutic vulnerability.<\/jats:p>","DOI":"10.1038\/s41419-026-09091-4","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:28:36Z","timestamp":1783398516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lactate-induced H3K4me3 histone mark promotes PLOD1-driven prostate cancer invasion"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2533-6646","authenticated-orcid":false,"given":"Marta","family":"Iozzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1668-2777","authenticated-orcid":false,"given":"Erica","family":"Pranzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gangarossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Roccabianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Sandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Benelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Comito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-1098","authenticated-orcid":false,"given":"Elisa","family":"Giannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"9091_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09695-9","volume":"10","author":"K Ortmayr","year":"2019","unstructured":"Ortmayr K, Dubuis S, Zampieri M. Metabolic profiling of cancer cells reveals genome-wide crosstalk between transcriptional regulators and metabolism. Nat Commun. 2019;10:1841.","journal-title":"Nat Commun"},{"key":"9091_CR2","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","volume":"55","author":"X Xu","year":"2023","unstructured":"Xu X, Peng Q, Jiang X, Tan S, Yang Y, Yang W, et al. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Exp Mol Med. 2023;55:1357\u201370.","journal-title":"Exp Mol Med"},{"key":"9091_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41420-025-02366-3","volume":"11","author":"J Yang","year":"2025","unstructured":"Yang J, Zhou F, Luo X, Fang Y, Wang X, Liu X, et al. Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies. Cell Death Discov. 2025;11:84.","journal-title":"Cell Death Discov"},{"key":"9091_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41574-022-00773-5","volume":"19","author":"JS Brunner","year":"2023","unstructured":"Brunner JS, Finley LWS. Metabolic determinants of tumour initiation. Nat Rev Endocrinol. 2023;19:134\u201350.","journal-title":"Nat Rev Endocrinol"},{"key":"9091_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01384-9","volume":"8","author":"J Simithy","year":"2017","unstructured":"Simithy J, Sidoli S, Yuan Z-F, Coradin M, Bhanu NV, Marchione DM, et al. Characterization of histone acylations links chromatin modifications with metabolism. Nat Commun. 2017;8:1141.","journal-title":"Nat Commun"},{"key":"9091_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cmet.2017.03.006","volume":"25","author":"GR Wagner","year":"2017","unstructured":"Wagner GR, Bhatt DP, O\u2019Connell TM, Thompson JW, Dubois LG, Backos DS, et al. A class of reactive Acyl-CoA species reveals the non-enzymatic origins of protein acylation. Cell Metab. 2017;25:823\u2013837.e8.","journal-title":"Cell Metab"},{"key":"9091_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.molcel.2025.02.011","volume":"85","author":"M Iozzo","year":"2025","unstructured":"Iozzo M, Pardella E, Giannoni E, Chiarugi P. The role of protein lactylation: a kaleidoscopic post-translational modification in cancer. Mol Cell. 2025;85:1263\u201379.","journal-title":"Mol Cell"},{"key":"9091_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2019.06.006","volume":"57","author":"C Thakur","year":"2019","unstructured":"Thakur C, Chen F. Connections between metabolism and epigenetics in cancers. Semin Cancer Biol. 2019;57:52\u201358.","journal-title":"Semin Cancer Biol"},{"key":"9091_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"9091_CR10","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/0008-5472.CAN-21-0914","volume":"82","author":"L Ippolito","year":"2022","unstructured":"Ippolito L, Comito G, Parri M, Iozzo M, Duatti A, Virgilio F, et al. Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer. Cancer Res. 2022;82:1267\u201382.","journal-title":"Cancer Res"},{"key":"9091_CR11","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1111\/febs.17423","volume":"292","author":"M Iozzo","year":"2025","unstructured":"Iozzo M, Comito G, Ippolito L, Sandrini G, Pardella E, Pranzini E, et al. Sex-related changes in lactate dehydrogenase A expression differently impact the immune response in melanoma. FEBS J. 2025;292:3056\u201371.","journal-title":"FEBS J"},{"key":"9091_CR12","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1038\/s41388-019-0688-7","volume":"38","author":"G Comito","year":"2019","unstructured":"Comito G, Iscaro A, Bacci M, Morandi A, Ippolito L, Parri M, et al. Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8\/miR21 axis. Oncogene. 2019;38:3681\u201395.","journal-title":"Oncogene"},{"key":"9091_CR13","doi-asserted-by":"publisher","unstructured":"Sgrignani G, Iozzo M, Di Leonardo L, Pardella E, Pranzini E, Gangarossa G et al. GPR55 senses lactate to sustain motility in prostate cancer cells. Mol Cell Biochem. 2025. https:\/\/doi.org\/10.1007\/s11010-025-05312-0.","DOI":"10.1007\/s11010-025-05312-0"},{"key":"9091_CR14","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-14-0319","volume":"74","author":"CL Roland","year":"2014","unstructured":"Roland CL, Arumugam T, Deng D, Liu SH, Philip B, Gomez S, et al. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res. 2014;74:5301\u201310.","journal-title":"Cancer Res"},{"key":"9091_CR15","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1038\/s44319-024-00180-z","volume":"25","author":"L Ippolito","year":"2024","unstructured":"Ippolito L, Duatti A, Iozzo M, Comito G, Pardella E, Lorito N, et al. Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer. EMBO Rep. 2024;25:3506\u201331.","journal-title":"EMBO Rep"},{"key":"9091_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi8602","volume":"7","author":"JT Noe","year":"2021","unstructured":"Noe JT, Rendon BE, Geller AE, Conroy LR, Morrissey SM, Young LEA, et al. Lactate supports a metabolic-epigenetic link in macrophage polarization. Sci Adv. 2021;7:eabi8602.","journal-title":"Sci Adv"},{"key":"9091_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.11","volume":"49","author":"K Hyun","year":"2017","unstructured":"Hyun K, Jeon J, Park K, Kim J. Writing, erasing and reading histone lysine methylations. Exp Mol Med. 2017;49:e324.","journal-title":"Exp Mol Med"},{"key":"9091_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06481-4","volume":"15","author":"X Cui","year":"2024","unstructured":"Cui X, Huo D, Wang Q, Wang Y, Liu X, Zhao K, et al. RUNX1\/NPM1\/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma. Cell Death Dis. 2024;15:98.","journal-title":"Cell Death Dis"},{"key":"9091_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01003-7","volume":"9","author":"HE Marei","year":"2025","unstructured":"Marei HE. Epigenetic regulators in cancer therapy and progression. NPJ Precis Oncol. 2025;9:206.","journal-title":"NPJ Precis Oncol"},{"key":"9091_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrg3173","volume":"13","author":"EL Greer","year":"2012","unstructured":"Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012;13:343\u201357.","journal-title":"Nat Rev Genet"},{"key":"9091_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-89","volume":"8","author":"AM Cervera","year":"2009","unstructured":"Cervera AM, Bayley J-P, Devilee P, McCreath KJ. Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol Cancer. 2009;8:89.","journal-title":"Mol Cancer"},{"key":"9091_CR22","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 2012;26:1326\u201338.","journal-title":"Genes Dev"},{"key":"9091_CR23","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature19353","volume":"537","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli M, Gon\u00e7alves E, Johnson TI, Zecchini VR, da Costa ASH, Gaude E, et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature. 2016;537:544\u20137.","journal-title":"Nature"},{"key":"9091_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biochi.2017.01.004","volume":"135","author":"JF Wentzel","year":"2017","unstructured":"Wentzel JF, Lewies A, Bronkhorst AJ, van Dyk E, du Plessis LH, Pretorius PJ. Exposure to high levels of fumarate and succinate leads to apoptotic cytotoxicity and altered global DNA methylation profiles in vitro. Biochimie. 2017;135:28\u201334.","journal-title":"Biochimie"},{"key":"9091_CR25","first-page":"60","volume":"1","author":"KL Cramer-Morales","year":"2020","unstructured":"Cramer-Morales KL, Heer CD, Mapuskar KA, Domann FE. Succinate accumulation links mitochondrial mnsod depletion to aberrant nuclear DNA methylation and altered cell fate. J Exp Pathol. 2020;1:60\u201370.","journal-title":"J Exp Pathol"},{"key":"9091_CR26","first-page":"916","volume":"60","author":"S Walenta","year":"2000","unstructured":"Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundf\u00f8r K, Rofstad EK, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916\u201321.","journal-title":"Cancer Res"},{"key":"9091_CR27","doi-asserted-by":"publisher","first-page":"23121","DOI":"10.1021\/acsomega.5c01286","volume":"10","author":"G Gangarossa","year":"2025","unstructured":"Gangarossa G, Iozzo M, Mugnaini G, Gelli R, Ippolito L, Giannoni E, et al. Setup of an in vitro three-dimensional stromalized prostate cancer model using gelatin microparticles. ACS Omega. 2025;10:23121\u20138.","journal-title":"ACS Omega"},{"key":"9091_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.cell.2025.02.023","volume":"188","author":"ZH Gray","year":"2025","unstructured":"Gray ZH, Honer MA, Ghatalia P, Shi Y, Whetstine JR. 20 years of histone lysine demethylases: from discovery to the clinic and beyond. Cell. 2025;188:1747\u201383.","journal-title":"Cell"},{"key":"9091_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-021-01989-5","volume":"40","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhou Q, Xie K, Cheng L, Peng S, Xie R, et al. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer. J Exp Clin Cancer Res. 2021;40:203.","journal-title":"J Exp Clin Cancer Res"},{"key":"9091_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1216-y","volume":"21","author":"S Punzi","year":"2019","unstructured":"Punzi S, Balestrieri C, D\u2019Alesio C, Bossi D, Dellino GI, Gatti E, et al. WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells. Breast Cancer Res. 2019;21:123.","journal-title":"Breast Cancer Res"},{"key":"9091_CR31","doi-asserted-by":"publisher","unstructured":"Cai WL, Chen JF-Y, Chen H, Wingrove E, Kurley SJ, Chan LH et al. Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation. Elife 2022; 11. https:\/\/doi.org\/10.7554\/eLife.78163.","DOI":"10.7554\/eLife.78163"},{"key":"9091_CR32","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1002\/1878-0261.12532","volume":"13","author":"Y Yamada","year":"2019","unstructured":"Yamada Y, Kato M, Arai T, Sanada H, Uchida A, Misono S, et al. Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target. Mol Oncol. 2019;13:1898\u2013912.","journal-title":"Mol Oncol"},{"key":"9091_CR33","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41388-020-01635-y","volume":"40","author":"Z Wang","year":"2021","unstructured":"Wang Z, Shi Y, Ying C, Jiang Y, Hu J. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-\u03baB signaling. Oncogene. 2021;40:1458\u201375.","journal-title":"Oncogene"},{"key":"9091_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101329","volume":"7","author":"C Zhang","year":"2025","unstructured":"Zhang C, Zhou Y, Hu M, Pan Y, Chen X, Sun Q, et al. PLOD1 promotes the malignancy of hepatocellular carcinoma by facilitating the NF-\u03baB\/IL-6\/STAT3-dependent TCA cycle. JHEP reports Innov Hepatol. 2025;7:101329.","journal-title":"JHEP reports Innov Hepatol"},{"key":"9091_CR35","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.7150\/jca.36801","volume":"11","author":"X-D Ye","year":"2020","unstructured":"Ye X-D, Qiu B-Q, Xiong D, Pei X, Jie N, Xu H, et al. High level of H3K4 tri-methylation modification predicts poor prognosis in esophageal cancer. J Cancer. 2020;11:3256\u201363.","journal-title":"J Cancer"},{"key":"9091_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.celrep.2015.02.006","volume":"10","author":"D Zhang","year":"2015","unstructured":"Zhang D, Wang Y, Shi Z, Liu J, Sun P, Hou X, et al. Metabolic reprogramming of cancer-associated fibroblasts by IDH3\u03b1 downregulation. Cell Rep. 2015;10:1335\u201348.","journal-title":"Cell Rep"},{"key":"9091_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S, et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab. 2023;5:61\u201379.","journal-title":"Nat Metab"},{"key":"9091_CR38","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202254685","volume":"23","author":"A Lopez Krol","year":"2022","unstructured":"Lopez Krol A, Nehring HP, Krause FF, Wempe A, Raifer H, Nist A, et al. Lactate induces metabolic and epigenetic reprogramming of pro-inflammatory Th17 cells. EMBO Rep. 2022;23:e54685.","journal-title":"EMBO Rep"},{"key":"9091_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","volume":"22","author":"AM Intlekofer","year":"2015","unstructured":"Intlekofer AM, Dematteo RG, Venneti S, Finley LWS, Lu C, Judkins AR, et al. Hypoxia induces production of L-2-Hydroxyglutarate. Cell Metab. 2015;22:304\u201311.","journal-title":"Cell Metab"},{"key":"9091_CR40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","volume":"23","author":"E Letouz\u00e9","year":"2013","unstructured":"Letouz\u00e9 E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell. 2013;23:739\u201352.","journal-title":"Cancer Cell"},{"key":"9091_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.celrep.2013.12.021","volume":"6","author":"BJ Klein","year":"2014","unstructured":"Klein BJ, Piao L, Xi Y, Rincon-Arano H, Rothbart SB, Peng D, et al. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers. Cell Rep. 2014;6:325\u201335.","journal-title":"Cell Rep"},{"key":"9091_CR42","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2013.04.019","volume":"17","author":"M Sciacovelli","year":"2013","unstructured":"Sciacovelli M, Guzzo G, Morello V, Frezza C, Zheng L, Nannini N, et al. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab. 2013;17:988\u201399.","journal-title":"Cell Metab"},{"key":"9091_CR43","doi-asserted-by":"publisher","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science 2020; 368. https:\/\/doi.org\/10.1126\/science.aaw5473.","DOI":"10.1126\/science.aaw5473"},{"key":"9091_CR44","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","volume":"71","author":"F Hirschhaeuser","year":"2011","unstructured":"Hirschhaeuser F, Sattler UGA, Mueller-Klieser W. Lactate: a metabolic key player in cancer. Cancer Res. 2011;71:6921\u20135.","journal-title":"Cancer Res"},{"key":"9091_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04940-4","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Li D, Liu H, Huang Y, Meng F, Tang J, et al. PHF13 epigenetically activates TGF\u03b2 driven epithelial to mesenchymal transition. Cell Death Dis. 2022;13:487.","journal-title":"Cell Death Dis"},{"key":"9091_CR46","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/cas.12166","volume":"104","author":"Y Yokoyama","year":"2013","unstructured":"Yokoyama Y, Hieda M, Nishioka Y, Matsumoto A, Higashi S, Kimura H, et al. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo. Cancer Sci. 2013;104:889\u201395.","journal-title":"Cancer Sci"},{"key":"9091_CR47","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.18632\/aging.102206","volume":"11","author":"W-H Xu","year":"2019","unstructured":"Xu W-H, Xu Y, Wang J, Tian X, Wu J, Wan F-N, et al. Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma. Aging (Albany NY). 2019;11:6503\u201321.","journal-title":"Aging (Albany NY)"},{"key":"9091_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04809-w","volume":"22","author":"M Ding","year":"2024","unstructured":"Ding M, Wang C, Hu J, She J, Shi R, Liu Y, et al. PLOD3 facilitated T cell activation in the colorectal tumor microenvironment and liver metastasis by the TNF-\u03b1\/ NF-\u03baB pathway. J Transl Med. 2024;22:30.","journal-title":"J Transl Med"},{"key":"9091_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1405-8","volume":"10","author":"J-H Baek","year":"2019","unstructured":"Baek J-H, Yun HS, Kwon GT, Lee J, Kim J-Y, Jo Y, et al. PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway. Cell Death Dis. 2019;10:156.","journal-title":"Cell Death Dis"},{"key":"9091_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2214942120","volume":"120","author":"Y Tong","year":"2023","unstructured":"Tong Y, Qi Y, Xiong G, Li J, Scott TL, Chen J, et al. The PLOD2\/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness. Proc Natl Acad Sci USA. 2023;120:e2214942120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9091_CR51","doi-asserted-by":"publisher","first-page":"11434","DOI":"10.18632\/aging.206029","volume":"16","author":"D-D Wang","year":"2024","unstructured":"Wang D-D, Li L, Fu Y-Q, Yang S-J, Chen X, Hou J-C, et al. Systematic characterization of the expression, prognosis and immune characteristics of PLOD family genes in breast cancer. Aging (Albany NY). 2024;16:11434\u201345.","journal-title":"Aging (Albany NY)"},{"key":"9091_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7150\/jca.35763","volume":"11","author":"S-S Li","year":"2020","unstructured":"Li S-S, Lian Y-F, Huang Y-L, Huang Y-H, Xiao J. Overexpressing PLOD family genes predict poor prognosis in gastric cancer. J Cancer. 2020;11:121\u201331.","journal-title":"J Cancer"},{"key":"9091_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109340","volume":"27","author":"Y Sun","year":"2024","unstructured":"Sun Y, Chen Y, Zhao H, Wang J, Liu Y, Bai J, et al. Lactate-driven type I collagen deposition facilitates cancer stem cell-like phenotype of head and neck squamous cell carcinoma. iScience. 2024;27:109340.","journal-title":"iScience"},{"key":"9091_CR54","unstructured":"Andrews S. FastQC: A quality control tool for high throughput sequence data. 2010.http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc."},{"key":"9091_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.107","volume":"2","author":"S Chen","year":"2023","unstructured":"Chen S. Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. iMeta. 2023;2:e107.","journal-title":"iMeta"},{"key":"9091_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"9091_CR57","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166\u20139.","journal-title":"Bioinformatics"},{"key":"9091_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"9091_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"9091_CR60","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang L-G, Yan G-R, He Q-Y. DOSE: an R\/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics. 2015;31:608\u20139.","journal-title":"Bioinformatics"},{"key":"9091_CR61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"9091_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26840-5","volume":"12","author":"M Bolis","year":"2021","unstructured":"Bolis M, Bossi D, Vallerga A, Ceserani V, Cavalli M, Impellizzieri D, et al. Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression. Nat Commun. 2021;12:7033.","journal-title":"Nat Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09091-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:47:48Z","timestamp":1790646468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09091-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9091"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09091-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All experimental procedures were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"843"}}